Lloyd Mackenzie - Net Worth and Insider Trading

Lloyd Mackenzie Net Worth

The estimated net worth of Lloyd Mackenzie is at least $0 dollars as of 2024-11-10. Lloyd Mackenzie is the COO of Neoleukin Therapeutics Inc and owns about 0 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $0. Details can be seen in Lloyd Mackenzie's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lloyd Mackenzie has not made any transactions after 2018-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lloyd Mackenzie

To

Lloyd Mackenzie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lloyd Mackenzie owns 1 companies in total, including Neoleukin Therapeutics Inc (NLTX) .

Click here to see the complete history of Lloyd Mackenzie’s form 4 insider trades.

Insider Ownership Summary of Lloyd Mackenzie

Ticker Comapny Transaction Date Type of Owner
NLTX Neoleukin Therapeutics Inc 2018-03-15 VP Technical Operations

Lloyd Mackenzie Latest Holdings Summary

Lloyd Mackenzie currently owns a total of 1 stock. Lloyd Mackenzie owns 0 shares of Neoleukin Therapeutics Inc (NLTX) as of March 15, 2018, with a value of $0.

Latest Holdings of Lloyd Mackenzie

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NLTX Neoleukin Therapeutics Inc 2018-03-15 0 3.49 0

Holding Weightings of Lloyd Mackenzie


Lloyd Mackenzie Form 4 Trading Tracker

According to the SEC Form 4 filings, Lloyd Mackenzie has made a total of 0 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 65 shares on March 15, 2018, which brought Lloyd Mackenzie around $19,048.

Insider Trading History of Lloyd Mackenzie

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lloyd Mackenzie Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lloyd Mackenzie Ownership Network

Ownership Network List of Lloyd Mackenzie

No Data

Ownership Network Relation of Lloyd Mackenzie

Insider Network Chart

Lloyd Mackenzie Owned Company Details

What does Neoleukin Therapeutics Inc do?

Who are the key executives at Neoleukin Therapeutics Inc?

Lloyd Mackenzie is the VP Technical Operations of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .

Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary

Over the past 18 months, Lloyd Mackenzie made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neoleukin Therapeutics Inc Insider Transactions

No Available Data

Lloyd Mackenzie Mailing Address

Above is the net worth, insider trading, and ownership report for Lloyd Mackenzie. You might contact Lloyd Mackenzie via mailing address: C/o Aquinox Pharmaceuticals, Inc., 450 - 887 Great Northern Way, Vancouver A1 V5t 4t5.